Category: Latest News
-
GMP Manufacturing Sale Gives MacroGenics Additional Non-Dilutive Capital for Pipeline Development (MGNX)
MacroGenics agreed to sell its GMP manufacturing operations to Bora Pharmaceuticals in a deal designed to strengthen its balance sheet and sharpen focus on its oncology pipeline. Key Investor Takeaways Why MGNX Stock Is in Focus MacroGenics (NASDAQ:MGNX) announced a definitive agreement to sell its GMP drug substance manufacturing operations to Bora Pharmaceuticals (USOTC:BORAY). Under…
-
Gross Margin Expansion Highlights Solésence’s Operational Restructuring Efforts (SLSN)
Solésence reported improved gross margin in the first quarter despite lower revenue and a return to a net loss, as the company continued executing its Transform & Transcend strategic initiative. Key Investor Takeaways Why SLSN Stock Is in Focus Solésence (NASDAQ:SLSN) released first-quarter 2026 results showing lower sales but improving margins as the company advanced…
-
Cannabis Revenue Decline Pressures Organigram Earnings Despite Germany Expansion (OGI)
Organigram reported weaker second-quarter revenue and profitability as vape and infused pre-roll sales slowed, while the company positioned its Sanity Group acquisition as a major international growth catalyst. Key Investor Takeaways Why OGI Stock Is in Focus Organigram (NASDAQ:OGI) reported second-quarter fiscal 2026 results showing declining sales and profitability amid operational challenges in key cannabis…
-
AI Memory Demand Drives Netlist First-Quarter Profitability Turnaround (NLST)
Strong growth in DDR5 and HBM memory product demand helped Netlist swing to profitability in the first quarter, highlighting rising exposure to AI infrastructure spending. Key Investor Takeaways Why NLST Stock Is in Focus Netlist (USOTC:NLST) reported a sharp improvement in first-quarter financial performance, supported by accelerating demand for advanced memory products tied to AI…
-
Novo Nordisk (NVO) Reports Strong Weight-Loss Results for Higher-Dose Wegovy
Novo Nordisk (NYSE:NVO) unveiled new clinical data on Tuesday showing that a higher 7.2 mg dose of Wegovy delivered substantial weight loss in people with obesity, regardless of how rapidly patients initially responded to treatment. The findings were presented at the European Congress on Obesity in Istanbul. STEP UP Trial Shows Greater Weight Loss With…
-
eBay (EBAY) Rejects GameStop (GME) Takeover Proposal as Financing Concerns Mount
eBay (NASDAQ:EBAY) has turned down a proposed $56 billion takeover offer from GameStop (NYSE:GME), citing concerns over the credibility and financing structure of the proposed transaction. The bid would have seen GameStop — a company valued at roughly one-quarter of eBay’s size — attempt one of the most ambitious acquisitions in the retail and e-commerce…
-
eToro (ETOR) Tops First-Quarter Estimates as Commodities Trading Jumps
eToro (NASDAQ:ETOR) reported first-quarter results on Tuesday that came in ahead of Wall Street expectations, supported by a sharp increase in commodities trading activity that helped counter softer cryptocurrency volumes. Shares of the company rose about 1.2% in pre-market trading following the earnings release. The online trading and investment platform posted adjusted earnings per share…
-
Under Armour (UAA) Shares Sink After Earnings Miss and Weak FY2027 Guidance
Shares of Under Armour (NYSE:UAA) fell more than 20% at Tuesday’s market open after the athletic apparel group reported quarterly results below analyst expectations and issued weaker-than-anticipated guidance for fiscal 2027. The company posted an adjusted loss of $0.03 per share for the fourth quarter, missing consensus estimates for a loss of $0.02 per share.…
-
Wendy’s (WEN) Shares Jump Following Report of Possible Take-Private Bid
Shares of Wendy’s (NASDAQ:WEN) surged as much as 12% in premarket trading on Tuesday after a report indicated that activist investor Nelson Peltz is exploring support for a potential bid to take the restaurant chain private. According to the Financial Times, Trian Fund Management has recently been in discussions with external investors, including groups in…
-
Lahontan Gold – Historic Mine Poised for a Comeback
Nevada Takes Center Stage The Iran conflict once again demonstrates why gold remains in demand as a safe-haven asset during times of geopolitical uncertainty. While rising oil prices fuel inflation fears and put pressure on capital markets, capital is increasingly flowing into defensive tangible assets. This creates an ideal scenario for gold companies with advanced…